PL1732556T3 - Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów - Google Patents

Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów

Info

Publication number: PL1732556T3
Authority: PL; Poland
Prior art keywords: benzopyran; piperazinyl; hydrates; salts; amino
Prior art date: 2004-03-25

Application number

PL05717126T

Other languages

English (en)

Inventor

Cornelis Bakker

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-25

Filing date

2005-03-23

Publication date

2008-09-30

2005-03-23 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2008-09-30 Publication of PL1732556T3 publication Critical patent/PL1732556T3/pl

Links

AHWHLBJKIFHNIV-UHFFFAOYSA-N 3-amino-8-piperazin-1-ylchromen-2-one Chemical compound C=12OC(=O)C(N)=CC2=CC=CC=1N1CCNCC1 AHWHLBJKIFHNIV-UHFFFAOYSA-N 0.000 title 1
150000004677 hydrates Chemical class 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pyrane Compounds (AREA)

PL05717126T 2004-03-25 2005-03-23 Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów PL1732556T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US55595804P	2004-03-25	2004-03-25
EP04101228		2004-03-25
PCT/EP2005/051326 WO2005092338A1 (en)	2004-03-25	2005-03-23	Process for the preparation of 3-amino-8-(1-piperazinyl) -2h-1-benzopyran-2-one and salts and hydrates thereof
EP05717126A EP1732556B1 (en)	2004-03-25	2005-03-23	Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and hydrates thereof

Publications (1)

Publication Number	Publication Date
PL1732556T3 true PL1732556T3 (pl)	2008-09-30

Family

ID=34928926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05717126T PL1732556T3 (pl)	2004-03-25	2005-03-23	Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów

Country Status (12)

Country	Link
US (2)	US7776860B2 (pl)
EP (1)	EP1732556B1 (pl)
JP (1)	JP2007530507A (pl)
AR (1)	AR049478A1 (pl)
AT (1)	ATE388709T1 (pl)
CA (1)	CA2554041A1 (pl)
DE (1)	DE602005005308T2 (pl)
ES (1)	ES2303674T3 (pl)
PL (1)	PL1732556T3 (pl)
SA (1)	SA05260061B1 (pl)
TW (1)	TWI340136B (pl)
WO (1)	WO2005092338A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
JP6061373B2 (ja) *	2012-07-24	2017-01-18	国立研究開発法人産業技術総合研究所	２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0189612B1 (en)	1984-12-21	1992-11-04	Duphar International Research B.V	New pharmaceutical compositions having a psychotropic activity
IL92544A0 (en)	1988-12-08	1990-08-31	Duphar Int Res	Piperazine derivatives,their preparation and pharmaceutical compositions containing them
US5009895A (en)	1990-02-02	1991-04-23	Merck & Co., Inc.	Sustained release with high and low viscosity HPMC
FR2670491B1 (fr)	1990-12-14	1993-02-05	Adir	Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
PT533268E (pt)	1991-09-18	2002-02-28	Glaxo Group Ltd	Derivados de benzanilida como antagonistas de 5-ht1d
WO1993013766A1 (en)	1992-01-07	1993-07-22	Merrell Dow Pharmaceuticals Inc.	Treatment of involuntary movements with 5ht1a receptor agonists
EP0650964A1 (en) *	1993-11-02	1995-05-03	Duphar International Research B.V	1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
US5478572A (en)	1994-09-06	1995-12-26	Bristol-Myers Squibb Co.	Gepirone dosage form
NL9401572A (nl)	1994-09-27	1996-05-01	Avebe Coop Verkoop Prod	Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
JP3989554B2 (ja)	1996-03-29	2007-10-10	デユフアー・インターナシヨナル・リサーチ・ベー・ブイ	ピペラジンおよびピペリジン化合物
GB9706089D0 (en)	1997-03-24	1997-05-14	Scherer Ltd R P	Pharmaceutical composition
PA8469101A1 (es)	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1
US6376494B1 (en)	1998-06-15	2002-04-23	American Home Products Corporation	Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US6312717B1 (en)	1998-07-07	2001-11-06	Bristol-Myers Squibb Company	Method for treatment of anxiety and depression
UA62015C2 (en)	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
GB0008563D0 (en)	2000-04-07	2000-05-24	Cambridge Discovery Chemistry	Investigating different physical and/or chemical forms of materials
JP2004231514A (ja)	2000-08-31	2004-08-19	Meiji Seika Kaisha Ltd	５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体
US20030008880A1 (en)	2001-05-02	2003-01-09	Pfizer Inc.	4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
AR039164A1 (es)	2002-03-28	2005-02-09	Synthon Bv	Sales de venlafaxina de baja solubilidad en agua
FR2837822B1 (fr) *	2002-03-29	2004-06-04	Bioprojet Soc Civ	Formes polymorphes du fasidotril, leurs procedes de preparation et compositions pharmaceutiques les contenant
US20050215551A1 (en) *	2004-03-25	2005-09-29	Solvay Pharmaceuticals B.V.	1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor

2005
- 2005-03-21 AR ARP050101091A patent/AR049478A1/es not_active Application Discontinuation
- 2005-03-22 SA SA05260061A patent/SA05260061B1/ar unknown
- 2005-03-22 TW TW094108777A patent/TWI340136B/zh not_active IP Right Cessation
- 2005-03-22 US US11/085,136 patent/US7776860B2/en not_active Expired - Fee Related
- 2005-03-23 AT AT05717126T patent/ATE388709T1/de not_active IP Right Cessation
- 2005-03-23 WO PCT/EP2005/051326 patent/WO2005092338A1/en not_active Ceased
- 2005-03-23 PL PL05717126T patent/PL1732556T3/pl unknown
- 2005-03-23 ES ES05717126T patent/ES2303674T3/es not_active Expired - Lifetime
- 2005-03-23 CA CA002554041A patent/CA2554041A1/en not_active Abandoned
- 2005-03-23 JP JP2007504416A patent/JP2007530507A/ja active Pending
- 2005-03-23 EP EP05717126A patent/EP1732556B1/en not_active Expired - Lifetime
- 2005-03-23 DE DE602005005308T patent/DE602005005308T2/de not_active Expired - Lifetime
2010
- 2010-07-02 US US12/829,554 patent/US8173660B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2303674T3 (es)	2008-08-16
JP2007530507A (ja)	2007-11-01
EP1732556B1 (en)	2008-03-12
US7776860B2 (en)	2010-08-17
TWI340136B (en)	2011-04-11
US20110003830A1 (en)	2011-01-06
EP1732556A1 (en)	2006-12-20
US8173660B2 (en)	2012-05-08
SA05260061B1 (ar)	2009-01-19
ATE388709T1 (de)	2008-03-15
WO2005092338A1 (en)	2005-10-06
CA2554041A1 (en)	2005-10-06
US20050215566A1 (en)	2005-09-29
DE602005005308D1 (de)	2008-04-24
AR049478A1 (es)	2006-08-09
DE602005005308T2 (de)	2009-10-08
TW200611900A (en)	2006-04-16

Publication	Publication Date	Title
IL192241A0 (en)	2008-12-29	Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
IL190137A0 (en)	2008-08-07	Crystals of laquinimod sodium, and process for the manufacture thereof
TWI349007B (en)	2011-09-21	Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
IL234893A (en)	2015-09-24	A process for making derivatives of piperazine and diazepanyl benzamide
SI1797037T1 (sl)	2015-06-30	Postopek priprave 4-(4-((((4-kloro-3-(trifluorometil)fenil)amino)karbonil)amino) fenioksi)N-metilpiridin-2-karboksamida
PT1802579E (pt)	2014-02-17	Derivados da 3-arilaminopiridina
IL198847A (en)	2015-07-30	Process for making 2-imino-thiazolidine-4-on and several such histories
ZA200710173B (en)	2009-09-30	Tygecycline and methods of preparing 9-nitrominocycline
ZA200903533B (en)	2010-03-31	Process for the preparation of rosuvastatin
ZA200701016B (en)	2008-05-28	Process for the preparation of isothiazole derivatives
SI1844036T1 (sl)	2015-12-31	Postopek za pripravo aripiprazola
EP2069307A4 (en)	2010-03-03	PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
EP1893625A4 (en)	2012-12-26	PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
GB2442160B (en)	2010-01-20	Preparation of escitalopram free base and salts
PL1732556T3 (pl)	2008-09-30	Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów
ZA200804732B (en)	2009-11-25	Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
PT1753720E (pt)	2014-08-04	Processo para a preparação de perindopril e sais do mesmo
IL178539A0 (en)	2007-02-11	Process for preparation of probucol derivatives
HU0401379D0 (en)	2004-09-28	Process for the preparation of risperidon
ZA200706203B (en)	2009-12-30	Processes and compounds for the preparation of substituted naphthylindole derivatives
SI1732916T1 (sl)	2007-10-31	Postopek za pripravo alkoksikarbonilmetoksi-ciklopentanov
GB0303691D0 (en)	2003-03-19	Model for development of vaccines
HK1115374A (en)	2008-11-28	Addition salts of tolperisone, processes for their preparation and use thereof
PL373059A1 (pl)	2006-09-04	Mieszanka ceramiczna i sposób otrzymywania mieszanki ceramicznej
PL372016A1 (pl)	2006-07-10	Sposób wytwarzania pochodnych N-fenylo-2-pirymidynoamin